Insider Selling: Hamilton Thorne Ltd (HTL) Director Sells 51,652 Shares of Stock

Hamilton Thorne Ltd (CVE:HTL) Director Meg Moray Spencer sold 51,652 shares of the firm’s stock in a transaction dated Thursday, February 8th. The stock was sold at an average price of C$0.64, for a total transaction of C$33,057.28.

Meg Moray Spencer also recently made the following trade(s):

  • On Tuesday, February 6th, Meg Moray Spencer sold 16,500 shares of Hamilton Thorne stock. The stock was sold at an average price of C$0.62, for a total transaction of C$10,230.00.

Hamilton Thorne Ltd (CVE HTL) traded up C$0.01 during trading on Wednesday, hitting C$0.84. 51,300 shares of the stock were exchanged, compared to its average volume of 118,383. Hamilton Thorne Ltd has a one year low of C$0.45 and a one year high of C$1.05. The company has a market cap of $86.13, a P/E ratio of 41.50 and a beta of 3.27.

Hamilton Thorne (CVE:HTL) last released its quarterly earnings data on Tuesday, November 21st. The company reported C$0.01 earnings per share for the quarter, hitting the Zacks’ consensus estimate of C$0.01. Hamilton Thorne had a net margin of 10.14% and a return on equity of 16.18%.

Separately, Bloom Burton restated a “buy” rating on shares of Hamilton Thorne in a research report on Wednesday, October 25th.

COPYRIGHT VIOLATION WARNING: “Insider Selling: Hamilton Thorne Ltd (HTL) Director Sells 51,652 Shares of Stock” was first posted by American Banking News and is owned by of American Banking News. If you are accessing this news story on another site, it was illegally copied and republished in violation of U.S. & international copyright & trademark legislation. The correct version of this news story can be read at

Hamilton Thorne Company Profile

Hamilton Thorne Ltd. is engaged in the development, manufacture and sale of precision laser devices and advanced image analysis systems for living cell applications in the fertility, stem cell and developmental biology research markets. The Company offers Clinical lasers, Research lasers and Clinical Sperm Analysis Products.

Receive News & Ratings for Hamilton Thorne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hamilton Thorne and related companies with's FREE daily email newsletter.

Leave a Reply